Log in

LON:CMBNCambian Group Share Price, Forecast & News

GBX 192.40
+192.40 (+∞)
(As of 10/18/2018)
Today's Range
Now: GBX 192.40
50-Day Range N/A
52-Week Range
Now: GBX 192.40
Average Volume191,881 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Cambian Group plc, together with its subsidiaries, provides specialist educational and behavioral health services for children in the United Kingdom. It offers services in the areas of autism and learning difficulties, residential care and education, therapeutic fostering care and emotional support, and deaf. The company delivers its services through a network of 222 specialist children's facilities in England and Wales. In addition, it is involved in property and trading businesses. The company was formerly known as Project Zelda plc and changed its name to Cambian Group plc in March 2014. Cambian Group plc was founded in 2003 and is based in London, the United Kingdom.
Read More
Cambian Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.64 out of 5 stars

Industry, Sector and Symbol

Industry Medical Care



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive CMBN News and Ratings via Email

Sign-up to receive the latest news and ratings for CMBN and its competitors with MarketBeat's FREE daily newsletter.

Cambian Group (LON:CMBN) Frequently Asked Questions

Has Cambian Group been receiving favorable news coverage?

Press coverage about CMBN stock has trended neutral on Sunday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cambian Group earned a news impact score of 0.4 on InfoTrie's scale. They also gave headlines about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Cambian Group.

Who are some of Cambian Group's key competitors?

What other stocks do shareholders of Cambian Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cambian Group investors own include CareTech (CTH), Adtalem Global Education (ATGE), Enquest (ENQ), Medicx Fund (MXF), Target Healthcare REIT (THRL), Ultra Petroleum (UPLMQ), Welltower (WELL), Bodycote (BOY), Diageo (DEO) and National Express Group (NUFMF).

Who are Cambian Group's key executives?

Cambian Group's management team includes the following people:
  • Mr. Saleem Asaria, CEO & Exec. Director (Age 53)
  • Mr. Anoop Kang, CFO & Exec. Director
  • Ms. Anne Marie Carrie, COO & Exec. Director (Age 62)
  • Ms. Catherine Jane Apthorpe, Head of Legal & Company Sec. (Age 39)
  • Mr. Mike McQuaid, Managing Director of Adult Services

What is Cambian Group's stock symbol?

Cambian Group trades on the London Stock Exchange (LON) under the ticker symbol "CMBN."

How do I buy shares of Cambian Group?

Shares of CMBN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Cambian Group's stock price today?

One share of CMBN stock can currently be purchased for approximately GBX 192.40.

What is Cambian Group's official website?

The official website for Cambian Group is www.cambiangroup.com.

How can I contact Cambian Group?

Cambian Group's mailing address is 4th Floor, Waterfront Building Chancellors Road, Hammersmith Embankment, LONDON, W6 9RU, United Kingdom. The health services provider can be reached via phone at +44-20-87356150.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.